Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BAY-3546828 by Bayer for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
BAY-3546828 is under clinical development by Bayer and currently in Phase I for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According to...